BARCELONA (Reuters) - Though speculation is rife of a new Pfizer bid, AstraZeneca's chief executive is not holed up with advisers in London or New York. Instead, he has spent the last three days immersed in heart science in Barcelona.

from Reuters: Top News http://ift.tt/1uf5ZiY
via IFTTT
from Reuters: Top News http://ift.tt/1uf5ZiY
via IFTTT
No hay comentarios:
Publicar un comentario